The Metabolomic Profile provides assessment of the likelihood of Metabolic syndrome in at-risk patients. The Metabolomic Profile evaluates five biomarkers that may reflect a patient’s risk of developing Metabolic syndrome, which is identified by a cluster of cardiometabolic risk factors, with insulin resistance and adiposity as its central features. Identification of individuals with metabolic syndrome is important due to its association with an increased risk of and type 2 diabetes mellitus and coronary heart disease.
Learn more »
3 to 5 days
Click any analyte name for additional clinical information, including reference ranges, specimen collection, stability and rejection criteria.
|Body Mass Index (BMI)||No|
List price applies when filing with insurance or Medicare, or when billing a patient directly.
Prompt payment pricing applies when billing to a physician account or prepayment is received with the test.
Doctor's Data offers profiles containing multiple analytes. *Multiple analytes may be billed under a single CPT code. Many analytes can be ordered individually. Pricing may vary. Click on a specific analyte for more information or read our detailed billing and payment policies.
The CPT codes listed on our website are for informational purposes only. This information is our interpretation of CPT coding requirements and may not necessarily be correct. You are advised to consult the CPT Coding Manual published by the American Medical Association. Doctor's Data, Inc. takes no responsibility for billing errors due to your use of any CPT information from our website.
Doctor’s Data offers the Metabolomic Profile due to increasing awareness of the need to detect Metabolic syndrome before it progresses to adult-onset diabetes and related health consequences. The profile is designed to assess the likelihood of Metabolic syndrome in at-risk patients. Metabolic syndrome may occur at all stages in life. The number of people with Metabolic syndrome has increased over the last two decades. In 2006 it was estimated that 13% of US adolescents, 24% of young – midlife adults, and 40% of senior adults (> 70 y.o.) have Metabolic syndrome.
Although the number of people with Metabolic syndrome is increasing, human genetics have not. Epigenetic, controllable factors clearly play a role in the development of Metabolic syndrome. Contributing factors may include obesity, insulin resistance, polycystic ovary disease, hormone imbalance or a sedentary, unhealthy (smoking, etc.) lifestyle. “Over nutrition” and poor dietary choices (highly processed, high fat, high salt, high sugar “empty-calorie” foods), combined with sedentary habits interact with our genetic programming: we store extra calories as fat. Fat cells (adipocytes) produce hormones (adipokines) that interact with the hypothalamus and or immune system and may have pro-inflammatory or anti-inflammatory effects. Altered adipokine levels have been observed in Metabolic syndrome. The biomarkers that constitute the Metabolomic Profile include: